[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) 

# Benef: __Reduction in airborne SARS-CoV-2__ (PBN__Benef_1119)

## Property: has_Beneficiary

* [patients](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_31.md)
* [healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_68.md)

## Property: has_BenefSource

* [conway-morris_removal_2021](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_232.md)

## Property: has_BenefReturn

* [Private investors would benefit from investing in air filtration devices as it would improve patient safety and reduce healthcare costs associated with hospital-acquired infections.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1251.md)

## Property: has_BenefDetails

Air filtration devices effectively remove airborne SARS-CoV-2, reducing the risk of hospital-acquired infections.

